The end-of-life care conundrum
pharmaphorum
JANUARY 3, 2023
The study that emerged from scientists at the Yale Cancer Center, working in collaboration with researchers from Flatiron Health, concluded that there is no difference between the overall use of systemic anti-cancer therapy at the end-of-life stage since 2015.
98 
Let's personalize your content